Atlas Trials

Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe

RecordFirmDate
A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women (NCT02210689)Actavis Inc.2014-01-01

Track Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe automatically

Every clearance here is in the API, with alerts when new ones post.